Krahn MD - Search Results

1

Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end points.

Bloomfield DJ, Krahn MD, Neogi T, Panzarella T, Smith TJ, Warde P, Willan AR, Ernst S, Moore MJ, Neville A, Tannock IF. Bloomfield DJ, et al. Among authors: krahn md. J Clin Oncol. 1998 Jun;16(6):2272-9. doi: 10.1200/JCO.1998.16.6.2272. J Clin Oncol. 1998. PMID: 9626231 Clinical Trial.

2

Screening for prostate cancer. A decision analytic view.

Krahn MD, Mahoney JE, Eckman MH, Trachtenberg J, Pauker SG, Detsky AS. Krahn MD, et al. JAMA. 1994 Sep 14;272(10):773-80. JAMA. 1994. PMID: 7521400

3

Principles of economic evaluation in cancer screening.

Krahn M, Naglie G. Krahn M, et al. Cancer Treat Res. 1996;86:25-40. doi: 10.1007/978-1-4613-1265-9_3. Cancer Treat Res. 1996. PMID: 8886436 Review. No abstract available.

4

Prostate specific antigen response to mitoxantrone and prednisone in patients with refractory prostate cancer: prognostic factors and generalizability of a multicenter trial to clinical practice.

Dowling AJ, Czaykowski PM, Krahn MD, Moore MJ, Tannock IF. Dowling AJ, et al. Among authors: krahn md. J Urol. 2000 May;163(5):1481-5. J Urol. 2000. PMID: 10751862

5

The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer.

Krahn MD, Bremner KE, Asaria J, Alibhai SM, Nam R, Tomlinson G, Jewett MA, Warde P, Naglie G. Krahn MD, et al. Urology. 2002 Aug;60(2):258-63. doi: 10.1016/s0090-4295(02)01712-0. Urology. 2002. PMID: 12137823

6

Kidney transplantation in the elderly: a decision analysis.

Jassal SV, Krahn MD, Naglie G, Zaltzman JS, Roscoe JM, Cole EH, Redelmeier DA. Jassal SV, et al. Among authors: krahn md. J Am Soc Nephrol. 2003 Jan;14(1):187-96. doi: 10.1097/01.asn.0000042166.70351.57. J Am Soc Nephrol. 2003. PMID: 12506151

7

Health-state utilities and quality of life in hepatitis C patients.

Chong CA, Gulamhussein A, Heathcote EJ, Lilly L, Sherman M, Naglie G, Krahn M. Chong CA, et al. Am J Gastroenterol. 2003 Mar;98(3):630-8. doi: 10.1111/j.1572-0241.2003.07332.x. Am J Gastroenterol. 2003. PMID: 12650799

8

Do older men benefit from curative therapy of localized prostate cancer?

Alibhai SM, Naglie G, Nam R, Trachtenberg J, Krahn MD. Alibhai SM, et al. Among authors: krahn md. J Clin Oncol. 2003 Sep 1;21(17):3318-27. doi: 10.1200/JCO.2003.09.034. J Clin Oncol. 2003. PMID: 12947068

9

Continued undertreatment of older men with localized prostate cancer.

Schwartz KL, Alibhai SM, Tomlinson G, Naglie G, Krahn MD. Schwartz KL, et al. Among authors: krahn md. Urology. 2003 Nov;62(5):860-5. doi: 10.1016/s0090-4295(03)00690-3. Urology. 2003. PMID: 14624909

10

Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer.

Panju AH, Breunis H, Cheung AM, Leach M, Fleshner N, Warde P, Duff-Canning S, Krahn M, Naglie G, Tannock I, Tomlinson G, Alibhai SM. Panju AH, et al. BJU Int. 2009 Mar;103(6):753-7. doi: 10.1111/j.1464-410X.2008.08156.x. Epub 2008 Oct 24. BJU Int. 2009. PMID: 19007370 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

365 results

Search Page

Filters